These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
6. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Rizzu P; van Mil SE; Anar B; Rosso SM; Donker Kaat L; Heutink P; van Swieten JC Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):944-6. PubMed ID: 16941655 [TBL] [Abstract][Full Text] [Related]
7. Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients. Kaivorinne AL; Krüger J; Udd B; Majamaa K; Remes AM Eur J Neurol; 2010 Nov; 17(11):1393-5. PubMed ID: 20412296 [TBL] [Abstract][Full Text] [Related]
8. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review. Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767 [TBL] [Abstract][Full Text] [Related]